| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6114684 | Autoimmunity Reviews | 2013 | 5 Pages |
Abstract
Corticosteroids are the first line of treatment, and multiple immunosuppressive drugs have been tried with varying degrees of success. Tumour necrosis factor (TNF)-alpha blockers are a category of immunosuppressive agents representing a recent novel therapeutic option in Cogan's syndrome.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
A. Greco, A. Gallo, M. Fusconi, G. Magliulo, R. Turchetta, C. Marinelli, G.F. Macri, A. De Virgilio, M. de Vincentiis,